Cargando…
The efficiency of biologic therapy in a group of patients with rheumatoid arthritis
Objectives. The following study aims to evaluate the monotherapy with biologic agents: Infliximab (IFX), Etanercept (ETA), Adalimumab (ADA) and Rituximab (RTX) in patients diagnosed with rheumatoid arthritis (RA). Methods. To achieve these objectives, the database of “Dr. I. Cantacuzino” Clinical Ho...
Autores principales: | Gavrilă, BI, Ciofu, C, Stoica, V, Panaitescu, E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Carol Davila University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397527/ https://www.ncbi.nlm.nih.gov/pubmed/25914745 |
Ejemplares similares
-
Biomarkers in Rheumatoid Arthritis, what is new?
por: Gavrilă, BI, et al.
Publicado: (2016) -
Trends of rheumatoid arthritis monitorization in Romania
por: Mogoşan, C, et al.
Publicado: (2010) -
Utility of different cardiovascular disease prediction
models in rheumatoid arthritis
por: Purcarea, A, et al.
Publicado: (2014) -
Rheumatoid arthritis: travelling biological era
a Romanian X–ray population
por: Mogosan, C, et al.
Publicado: (2009) -
Patients'perspectives and motivators to participate in clinical trials with novel therapies for rheumatoid arthritis
por: Udrea, G, et al.
Publicado: (2009)